AltPep is a biomedical startup with a breakthrough approach for diagnosing and treating amyloid diseases
We are currently focusing on CNS disorders, in particular Alzheimer’s Disease.
Learn moreOur platform
The AltPepTM Platform is based on a collection of de novo designed synthetic peptides. The growing library is an arsenal that specifically targets the root causes of disease at the molecular level.
SOBATM
For the early detection and tracking of amyloid diseases Diagnostics using plasma and CSF
SOBINTM
These peptides target the toxic Aβ oligomers, neutralizing toxicity and inhibiting the disease